| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |